- Home
- DLHC vs ONCY Comparison
DLHC vs ONCY Comparison
Compare DLHC & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- ONCY
- Stock Information
- Founded
- DLHC 1969
- ONCY 1998
- Country
- DLHC United States
- ONCY Canada
- Employees
- DLHC N/A
- ONCY N/A
- Industry
- DLHC Business Services
- ONCY Pharmaceuticals and Biotechnology
- Sector
- DLHC Consumer Discretionary
- ONCY Health Care
- Exchange
- DLHC Nasdaq
- ONCY Nasdaq
- Market Cap
- DLHC 59.7M
- ONCY 49.1M
- IPO Year
- DLHC N/A
- ONCY 1999
- Fundamental
- Price
- DLHC $5.32
- ONCY $0.35
- Analyst Decision
- DLHC
- ONCY Strong Buy
- Analyst Count
- DLHC 0
- ONCY 4
- Target Price
- DLHC N/A
- ONCY $4.33
- AVG Volume (30 Days)
- DLHC 47.7K
- ONCY 847.4K
- Earning Date
- DLHC 05-07-2025
- ONCY 05-14-2025
- Dividend Yield
- DLHC N/A
- ONCY N/A
- EPS Growth
- DLHC 75.08
- ONCY N/A
- EPS
- DLHC 0.38
- ONCY N/A
- Revenue
- DLHC $377,074,000.00
- ONCY N/A
- Revenue This Year
- DLHC N/A
- ONCY N/A
- Revenue Next Year
- DLHC N/A
- ONCY N/A
- P/E Ratio
- DLHC $14.02
- ONCY N/A
- Revenue Growth
- DLHC N/A
- ONCY N/A
- 52 Week Low
- DLHC $2.72
- ONCY $0.33
- 52 Week High
- DLHC $12.23
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- DLHC 71.13
- ONCY 25.67
- Support Level
- DLHC $4.98
- ONCY $0.33
- Resistance Level
- DLHC $5.29
- ONCY $0.45
- Average True Range (ATR)
- DLHC 0.20
- ONCY 0.04
- MACD
- DLHC 0.02
- ONCY -0.01
- Stochastic Oscillator
- DLHC 94.74
- ONCY 8.10
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.